HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $782,401 | -85.5% | 9,455 | -88.3% | 0.02% | -70.6% |
| Q2 2021 | $5,394,000 | +330.5% | 80,935 | +617.1% | 0.05% | +325.0% |
| Q1 2021 | $1,253,000 | +39.8% | 11,287 | +12.9% | 0.01% | -53.8% |
| Q2 2020 | $896,000 | +326.7% | 10,000 | +374.6% | 0.03% | +420.0% |
| Q1 2020 | $210,000 | -83.1% | 2,107 | -80.6% | 0.01% | -80.8% |
| Q4 2019 | $1,246,000 | +41.1% | 10,844 | +54.8% | 0.03% | +18.2% |
| Q3 2019 | $883,000 | -19.8% | 7,003 | -23.5% | 0.02% | 0.0% |
| Q2 2019 | $1,101,000 | -63.1% | 9,150 | -73.1% | 0.02% | -71.4% |
| Q1 2019 | $2,980,000 | +960.5% | 34,062 | +443.3% | 0.08% | +1440.0% |
| Q3 2017 | $281,000 | -77.9% | 6,270 | -80.6% | 0.01% | -75.0% |
| Q2 2017 | $1,274,000 | +278.0% | 32,254 | +246.6% | 0.02% | +300.0% |
| Q3 2016 | $337,000 | – | 9,307 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |